Dominique Valeyre

38.3k total citations · 8 hit papers
401 papers, 18.8k citations indexed

About

Dominique Valeyre is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Epidemiology. According to data from OpenAlex, Dominique Valeyre has authored 401 papers receiving a total of 18.8k indexed citations (citations by other indexed papers that have themselves been cited), including 295 papers in Pulmonary and Respiratory Medicine, 233 papers in Physiology and 61 papers in Epidemiology. Recurrent topics in Dominique Valeyre's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (262 papers), Sarcoidosis and Beryllium Toxicity Research (204 papers) and Medical Imaging and Pathology Studies (54 papers). Dominique Valeyre is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (262 papers), Sarcoidosis and Beryllium Toxicity Research (204 papers) and Medical Imaging and Pathology Studies (54 papers). Dominique Valeyre collaborates with scholars based in France, United States and Germany. Dominique Valeyre's co-authors include Hilario Nunès, Pierre‐Yves Brillet, Talmadge E. King, Roland M. du Bois, Ulrich Costabel, Paul W. Noble, Carlo Albera, Williamson Z. Bradford, Lisa Lancaster and Steven A. Sahn and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and The Journal of Experimental Medicine.

In The Last Decade

Dominique Valeyre

372 papers receiving 18.3k citations

Hit Papers

Functional Delineation an... 2005 2026 2012 2019 2009 2011 2013 2005 2011 500 1000 1.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Functional Delineation and Differentiation Dynamics of Human CD4+ T Cells Expressing the FoxP3 Transcription Factor
    2009 1.8k citations Makoto Miyara, Christophe Parizot et al. profile →
  2. Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials
    2011 1.5k citations Paul W. Noble, Carlo Albera et al. profile →
  3. Sarcoidosis
    2013 710 citations Dominique Valeyre, Hilario Nunès et al. profile →
  4. Combined pulmonary fibrosis and emphysema: a distinct underrecognised entity
    2005 655 citations Vincent Cottin, Hilario Nunès et al. profile →
  5. BUILD-3: A Randomized, Controlled Trial of Bosentan in Idiopathic Pulmonary Fibrosis
    2011 440 citations Talmadge E. King, Kevin M. Brown et al. American Journal of Respiratory and Critical Care Medicine profile →
  6. Forced Vital Capacity in Patients with Idiopathic Pulmonary Fibrosis: Test Properties and Minimal Clinically Important Difference
    2011 356 citations Roland M. du Bois, Derek Weycker et al. American Journal of Respiratory and Critical Care Medicine profile →
  7. Pirfenidone for idiopathic pulmonary fibrosis: analysis of pooled data from three multinational phase 3 trials
    2015 320 citations Paul W. Noble, Carlo Albera et al. profile →
  8. Sarcoidosis: A Clinical Overview from Symptoms to Diagnosis
    2021 184 citations Yves Pachéco, Alain Calender et al. Cells profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dominique Valeyre France 66 13.1k 8.4k 2.7k 2.5k 2.0k 401 18.8k
Ulrich Costabel Germany 73 16.5k 1.3× 8.8k 1.0× 2.9k 1.1× 1.1k 0.4× 1.8k 0.9× 445 20.7k
Ganesh Raghu United States 81 22.0k 1.7× 7.6k 0.9× 3.6k 1.3× 1.3k 0.5× 2.7k 1.4× 332 26.7k
Luca Richeldi Italy 65 13.1k 1.0× 4.8k 0.6× 3.9k 1.5× 1.2k 0.5× 2.5k 1.2× 356 18.3k
Vincent Cottin France 72 16.2k 1.2× 5.0k 0.6× 3.3k 1.2× 1.0k 0.4× 1.7k 0.8× 524 19.4k
Kevin K. Brown United States 70 12.2k 0.9× 4.8k 0.6× 2.5k 0.9× 1.7k 0.7× 1.0k 0.5× 203 15.3k
Jay H. Ryu United States 84 16.3k 1.2× 8.1k 1.0× 3.8k 1.4× 605 0.2× 3.5k 1.7× 421 22.3k
Martin Kolb Canada 62 10.6k 0.8× 2.8k 0.3× 1.3k 0.5× 1.2k 0.5× 1.5k 0.8× 279 14.9k
Roland M. du Bois United Kingdom 69 16.2k 1.2× 6.2k 0.7× 3.2k 1.2× 988 0.4× 1.2k 0.6× 143 19.5k
Toby M. Maher United Kingdom 63 12.7k 1.0× 3.8k 0.5× 2.4k 0.9× 1.1k 0.5× 794 0.4× 437 15.6k
Annie Pardo Mexico 70 14.0k 1.1× 2.7k 0.3× 1.5k 0.5× 1.5k 0.6× 1.5k 0.7× 193 18.7k

Countries citing papers authored by Dominique Valeyre

Since Specialization
Citations

This map shows the geographic impact of Dominique Valeyre's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dominique Valeyre with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dominique Valeyre more than expected).

Fields of papers citing papers by Dominique Valeyre

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dominique Valeyre. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dominique Valeyre. The network helps show where Dominique Valeyre may publish in the future.

Co-authorship network of co-authors of Dominique Valeyre

This figure shows the co-authorship network connecting the top 25 collaborators of Dominique Valeyre. A scholar is included among the top collaborators of Dominique Valeyre based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dominique Valeyre. Dominique Valeyre is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jeny, Florence, Dominique Valeyre, Elyse E. Lower, & Robert P. Baughman. (2025). Advanced pulmonary sarcoidosis. Journal of Autoimmunity. 152. 103397–103397. 1 indexed citations
2.
Jeny, Florence, Deepak Talwar, Ogugua Ndili, et al.. (2024). Sarcoidosis Diagnostic Score (SDS) system: Impact of race, sex, organ involvement and duration of symptoms prior to diagnosis. Respiratory Medicine and Research. 86. 101127–101127.
3.
Besnard, Valérie, et al.. (2024). Complete response to mTOR inhibitor following JAKi failure in severe pulmonary sarcoidosis: Authors’ reply. Pulmonology. 31(1). 2422210–2422210.
4.
Pastré, Jean, Diane Bouvry, Karine Juvin, et al.. (2021). Sarcoidosis-Like Cancer-Associated Granulomatosis: Characteristics and a Case-Control Comparison with Sarcoidosis. Journal of Clinical Medicine. 10(9). 1988–1988. 3 indexed citations
5.
Pachéco, Yves, Dominique Valeyre, Thomas El Jammal, et al.. (2021). Autophagy and Mitophagy-Related Pathways at the Crossroads of Genetic Pathways Involved in Familial Sarcoidosis and Host-Pathogen Interactions Induced by Coronaviruses. Cells. 10(8). 1995–1995. 10 indexed citations
6.
Sesé, Lucile, Florence Jeny, Y. Uzunhan, et al.. (2020). Adult interstitial lung diseases and their epidemiology. La Presse Médicale. 49(2). 104023–104023. 10 indexed citations
7.
Nathan, Nadia, Chiara Siléo, Alain Calender, et al.. (2018). Paediatric sarcoidosis. Paediatric Respiratory Reviews. 29. 53–59. 23 indexed citations
8.
Bernard, Olivier, Alain Bruhat, Pierre Fafournoux, et al.. (2018). HIF-1α triggers ER stress and CHOP-mediated apoptosis in alveolar epithelial cells, a key event in pulmonary fibrosis. Scientific Reports. 8(1). 17939–17939. 122 indexed citations
9.
Vancheri, Carlo, Michael Kreuter, Luca Richeldi, et al.. (2017). Nintedanib with Add-on Pirfenidone in Idiopathic Pulmonary Fibrosis. Results of the INJOURNEY Trial. American Journal of Respiratory and Critical Care Medicine. 197(3). 356–363. 208 indexed citations
10.
Droitcourt, C., M. Rybojad, Raphaël Porcher, et al.. (2014). A Randomized, Investigator-Masked, Double-Blind, Placebo-Controlled Trial on Thalidomide in Severe Cutaneous Sarcoidosis. CHEST Journal. 146(4). 1046–1054. 29 indexed citations
11.
King, Talmadge E., Carlo Albera, Williamson Z. Bradford, et al.. (2014). All-Cause Mortality Rate in Patients with Idiopathic Pulmonary Fibrosis. Implications for the Design and Execution of Clinical Trials. American Journal of Respiratory and Critical Care Medicine. 189(7). 825–831. 101 indexed citations
12.
King, Talmadge E., Kevin M. Brown, Ganesh Raghu, et al.. (2011). BUILD-3: A Randomized, Controlled Trial of Bosentan in Idiopathic Pulmonary Fibrosis. American Journal of Respiratory and Critical Care Medicine. 184(1). 92–99. 440 indexed citations breakdown →
13.
Bois, Roland M. du, Derek Weycker, Carlo Albera, et al.. (2011). Forced Vital Capacity in Patients with Idiopathic Pulmonary Fibrosis: Test Properties and Minimal Clinically Important Difference. American Journal of Respiratory and Critical Care Medicine. 184(12). 1382–1389. 356 indexed citations breakdown →
14.
Bois, Roland M. du, Derek Weycker, Carlo Albera, et al.. (2011). Ascertainment of Individual Risk of Mortality for Patients with Idiopathic Pulmonary Fibrosis. American Journal of Respiratory and Critical Care Medicine. 184(4). 459–466. 297 indexed citations
15.
Bois, Roland M. du, Derek Weycker, Carlo Albera, et al.. (2010). Six-Minute-Walk Test in Idiopathic Pulmonary Fibrosis: Test Validation and Minimal Clinically Important Difference. American Journal of Respiratory and Critical Care Medicine. 183(9). 1231–1237. 330 indexed citations
16.
Valeyre, Dominique, Olivia Freynet, Geneviève Dion, et al.. (2009). Épidémiologie des pneumopathies infiltrantes diffuses. La Presse Médicale. 39(1). 53–59. 11 indexed citations
17.
Marchal-Sommé, J., Y. Uzunhan, S. Marchand‐Adam, et al.. (2007). Dendritic Cells Accumulate in Human Fibrotic Interstitial Lung Disease. American Journal of Respiratory and Critical Care Medicine. 176(10). 1007–1014. 96 indexed citations
18.
Miyara, Makoto, Zahir Amoura, Christophe Parizot, et al.. (2006). The immune paradox of sarcoidosis and regulatory T cells. The Journal of Experimental Medicine. 203(2). 359–370. 337 indexed citations
19.
Soler, Paul, Anne Bergeron, Marianne Kambouchner, et al.. (2000). Is High-Resolution Computed Tomography a Reliable Tool to Predict the Histopathological Activity of Pulmonary Langerhans Cell Histiocytosis?. American Journal of Respiratory and Critical Care Medicine. 162(1). 264–270. 45 indexed citations
20.
Crestani, Bruno, et al.. (1998). Bronchiolitis Obliterans Organizing Pneumonia Syndrome Primed by Radiation Therapy to the Breast. American Journal of Respiratory and Critical Care Medicine. 158(6). 1929–1935. 121 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ulrich Costabel Breakdown of academic impact, for papers by Ganesh Raghu Breakdown of academic impact, for papers by Luca Richeldi Breakdown of academic impact, for papers by Vincent Cottin Breakdown of academic impact, for papers by Kevin K. Brown Breakdown of academic impact, for papers by Jay H. Ryu Breakdown of academic impact, for papers by Martin Kolb Breakdown of academic impact, for papers by Roland M. du Bois Breakdown of academic impact, for papers by Toby M. Maher Breakdown of academic impact, for papers by Annie Pardo
Rankless by CCL
2026